Cyclooxygenase-2 (COX-2) inhibitors have been shown to improve survival in the SOD1-G93A ALS mouse model [103] and to reduce expression of cytosolic PLA2 (cPLA2). Here, SOD1 is linked to amyotrophic lateral sclerosis.